Skip to main content English

Publikationen 2018

  • S. Beinhardt, R. Al-Zoairy, K. Kozbial, AF. Stättermayer, A. Maieron, R. Stauber, M. Strasser, H. Zoller, I. Graziadei, S. Rasoul-Rockenschaub, M. Trauner, P. Ferenci, H. Hofer
    Long-term follow-up of ribavirin-free DAA-based treatment in HCV recurrence after orthotopic liver transplantation.
    Liver Int. 2018 Jul;38(7):1188-1197
     
  • T. Bucsics, M. Schoder, M. Diermayr, M. Feldner-Busztin, N. Goeschl, D. Bauer, P. Schwabl, M. Mandorfer, B. Angermayr, M. Cejna, A. Ferlitsch, W. Sieghart, M. Trauner, M. Peck-Radosavljevic, J. Karner, F. Karnel, T. Reiberger
    Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience
    PLoS One. 2018 Jan 9;13(1):e0189414
     
  • D. Chromy, P. Schwabl, T. Bucsics, B. Scheiner, R. Strassl, F. Mayer, MC.
    Aichelburg, K. Grabmeier-Pfistershammer, M. Trauner, M. Peck-Radosavljevic, T. Reiberger, M. Mandorfer
    Non-invasive liver fibrosis assessment and HCV treatment initiation within a systematic screening program in HIV/HCV coinfected patients.
    Wien Klin Wochenschr. 2018 Feb;130(3-4):105-114
     
  • Y. Kamogawa-Schifter, Y. Yamaoka, T. Uchida, A. Beer, B. Tribl, M. Schöniger-
    Hekele, M. Trauner, W. Dolak 
  • Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and
    duodenal ulcer at an Austrian tertiary referral center over 25 years.
    PLoS One. 2018 May 29;13(5):e0197695
     
  • A. Drolz, T. Horvatits, K. Roedl, K. Rutter, R. Brunner, C. Zauner, P. Schellongowski, G. Heinz, GC. Funk, M. Trauner, B. Schneeweiss, V. Fuhrmann
    Acid-base status and its clinical implications in critically ill patients with cirrhosis,
    acute-on-chronic liver failure and without liver disease
    Ann Intensive Care. 2018 Apr 19;8(1):48
     
  • A. Drolz, T. Horvatits, K. Rutter, F. Landahl, K. Roedl, P. Meersseman, A. Wilmer, J. Kluwe, AW. Lohse, S. Kluge, M. Trauner, V. Fuhrmann
    Lactate improves prediction of short-term mortality in critically ill cirrhosis patients: a multinational study.
    Hepatology. 2018 Aug 2
     
  • A. Eser, C. Primas, S. Reinisch, H. Vogelsang, G. Novacek, DR. Mould, W. Reinisch
    Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System
    J Clin Pharmacol. 2018 Jan 30.
  • JJ. Feld, DE. Bernstein, Z. Younes, HV. Vlierberghe, L.Larsen, F. Tatsch, P. Ferenci
    Ribavirin dose management in HCV patients receiving  ombitasvir / paritaprevir/ritonavir and dasabuvir with ribavirin
    Liver Int. 2018 Jan 27.
     
  • Weiss KH, Członkowska A, Hedera P, Ferenci P.
    WTX101 - an investigational drug for the treatment of Wilson disease.
    Expert Opin Investig Drugs. 2018 Jun 8:1-7
     
  • R. Schwarzer, D. Kivaranovic, M. Mandorfer, R. Paternostro, D. Wolrab, B. Heinisch, T. Reiberger, M. Ferlitsch, C. Gerner, M. Trauner, M. Peck-Radosavljevic, A. Ferlitsch
    Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal
    hypertension
    Aliment Pharmacol Ther. 2018 Jan;47(1):86-94
     
  • R. Schwarzer, D. Kivaranovic, R. Paternostro, M. Mandorfer, T. Reiberger, M. Trauner, M. Peck-Radosavljevic, A. Ferlitsch
    Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study
    Aliment Pharmacol Ther. 2018 Apr;47(8):1162-1169
     
  • I. Gessl, E. Waldmann, M. Britto-Arias, D. Penz, E. Pablik, M. Trauner, M. Ferlitsch
    Surveillance colonoscopy in Austria: Are we following the guidelines?
    Endoscopy. 2018 Feb;50(2):119-127
     
  • A. Frick, V. Khare, G. Paul, M. Lang, F. Ferk, S. Knasmüller, A. Beer, G. Oberhuber, C. Gasche
    Overt Increase of Oxidative Stress and DNA Damage in Murine and Human Colitis and Colitis-Associated Neoplasia
    Mol Cancer Res. 2018 Apr;16(4):634-642
     
  • CD. Fuchs, G. Paumgartner, V. Mlitz, V. Kunczer, E. Halilbasic, N. Leditznig, A. Wahlström, M. Ståhlman, A. Thüringer, K. Kashofer, T. Stojakovic, HU. Marschall, M. Trauner
    Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2-/- mice by modulating composition, signalling and excretion of faecal bile acids
    Gut. 2018 Apr 10. pii: gutjnl-2017-314553
     
  • N. Granofszky, M. Lang, V. Khare, G. Schmid, T. Scharl, F. Ferk, K. Jimenez, S. Knasmüller, C. Campregher, C. Gasche
    Identification of PMN-released mutagenic factors in a co-culture model for colitisassociated cancer
    Carcinogenesis. 2018 Feb 9;39(2):146-157
     
  • J. Gautherot, T. Claudel, F. Cuperus, CD. Fuchs, T. Falguieres, M. Trauner
    Thyroid hormone receptor β1 stimulates ABCB4 to increase biliary phosphatidylcholine excretion in mice.
    J Lipid Res. 2018 Jun 12
     
  • V. Hammer, K. Hammer, N. Memaran, WD. Huber, K. Hammer, J. Hammer 
    Correction to: Relationship Between Abdominal Symptoms and Fructose Ingestion in Children with Chronic Abdominal Pain
    Dig Dis Sci. 2018 Apr 2. doi: 10.1007/s10620-018-5046-z
     
  • J. Hammer
    Identification of Individuals with Functional Dyspepsia With a Simple, Minimally Invasive Test: A Single Center Cohort Study of the Oral Capsaicin Test
    Am J Gastroenterol. 2018 Apr;113(4):584-592
     
  • P. Jha P, MT. McDevitt, E. Halilbasic, EG. Williams, PM. Quiros, K. Gariani, MB.
    Sleiman, R. Gupta, A. Ulbrich, A. Jochem, JJ. Coon, M. Trauner, DJ. Pagliarini, J. Auwerx
    Genetic Regulation of Plasma Lipid Species and Their Association with Metabolic Phenotypes.
    Cell Syst. 2018 Jun 27;6(6):709-721
     
  • UJ. Lemberger, CD. Fuchs, C. Schöfer, A. Bileck, C. Gerner, T. Stojakovic, MM. Taketo, M. Trauner, G. Egger, C. Österreicher
    Hepatocyte specific expression of an oncogenic variant of β-catenin results in lethal metabolic dysfunction in mice
    Oncotarget. 2018 Jan 30;9(13):11243-11257
     
  • K. Kozbial, S. Moser, R. Al-Zoairy, R. Schwarzer, C. Datz, R. Stauber, H. Laferl, M. Strasser, S. Beinhardt, AF. Stättermayer, M. Gschwantler, H. Zoller, A.  Maieron, I. Graziadei, M. Trauner, P. Steindl-Munda, H. Hofer, P. Ferenci
    Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment.
    Liver Int. 2018 Jun;38(6):1028-1035
     
  • P. Königshofer, K. Brusilovskaya, P. Schwabl, T. Reiberger
    Animal models of portal hypertension.
    Biochim Biophys Acta. 2018 Jul 25
     
  • C. Madl, U. Madl
    Gastrointestinal motility in critically ill patients
    Med Klin Intensivmed Notfmed. 2018 Jun;113(5):433-442
     
  • M. Mandorfer, T. Reiberger, M. Peck-Radosavljevic
    Monitoring the Evolution of Portal Hypertension After Sustained Virologic Response.
    Gastroenterology. 2018 Apr;154(5):1550-1551
     
  • M. Mandorfer, P. Schwabl, R. Paternostro, K. Pomej, D. Bauer, J. Thaler, C. Ay, P. Quehenberger, M. Fritzer-Szekeres, M. Peck-Radosavljevic, M. Trauner, T.
    Reiberger, A. Ferlitsch; Vienna Hepatic Hemodynamic Lab
    Von Willebrand factor indicates bacterial translocation, inflammation, and
    procoagulant imbalance and predicts complications independently of portal  hypertension severity.
    Aliment Pharmacol Ther. 2018 Apr;47(7):980-988
     
  • M. Mandorfer, T. Bucsics, V. Hutya, K. Schmid-Scherzer, B. Schaefer, H. Zoller, A. Ferlitsch, M. Peck-Radosavljevic, M. Trauner, P. Ferenci, M. Kneussl, T. Reiberger 
    Liver disease in adults with α1-antitrypsin deficiency.
    United European Gastroenterol J. 2018 Jun;6(5):710-718
     
  • M. Mandorfer, B. Scheiner, AF. Stättermayer, P. Schwabl, R. Paternostro, D. Bauer, B. Schaefer, H. Zoller, M. Peck-Radosavljevic, M. Trauner, T. Reiberger, P. Ferenci, A. Ferlitsch
    Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.
    Aliment Pharmacol Ther. 2018 Jun 29
     
  • G. Moser, C. Fournier, J. Peter
    Intestinal microbiome-gut-brain axis and irritable bowel syndrome 
    Wien Med Wochenschr. 2018 Mar;168(3-4):62-66
     
  • W. Miehsler, C. Dejaco, HP. Gröchenig, H. Fuchssteiner, C. Högenauer, L. Kazemi Shirazi, H. Maier, A. Mayer, A. Moschen, W. Reinisch, W. Petritsch, R. Platzer, P. Steiner, H. Tilg, H. Vogelsang, H. Wenzl, G. Novacek
    Second Austrian consensus on the safe use of anti-TNFα-antibodies in patients with inflammatory bowel diseases
    Z Gastroenterol. 2018 Mar;56(3):275-302
     
  • R. Paternostro, BB. Heinisch, T. Reiberger, M. Mandorfer, R. Schwarzer, B. Seeland, M. Trauner, M. Peck-Radosavljevic, A. Ferlitsch
    Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension
    Liver Int. 2018 Jan 24.
     
  • M. Pinter, WJ. Kwanten, RK. Jain
    Renin-angiotensin system inhibitors to mitigate cancer treatment-related adverse events
    Clin Cancer Res. 2018 Apr 2
     
  • C. Primas, H. Vogelsang, M. Bergmann
    Inflammatory bowel disease: What does the clinician want to know from the radiologist?
    Radiologe. 2018 Apr;58(4):320-325
     
  • N. Pfisterer, C. Dexheimer, EM. Fuchs, T. Bucsics, P. Schwabl, M. Mandorfer, I. Gessl, L. Sandrieser, L. Baumann, F. Riedl, B. Scheiner, T. Pachofszky, W. Dolak, C. Schrutka-Kölbl, A. Ferlitsch, M. Schöniger-Hekele, M. Peck-Radosavljevic, M. Trauner, C. Madl, T. Reiberger
    Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.
    Aliment Pharmacol Ther. 2018 Apr;47(7):966-979
     
  • GH. Lo, T. Reiberger
    Peptic ulcer bleeding in patients with cirrhosis: Is it as bad as variceal bleeding?
    Hepatology. 2018 Apr;67(4):1219-1220
     
  • W. Reinisch, K. Hung, M. Hassan-Zahraee, F. Cataldi
    Targeting endothelial ligands: (ICAM-1/Alicaforsen, MAdCAM-1)
    J Crohns Colitis. 2018 May 11.
     
  • W. Reinisch, JF. Colombel, PR. Gibson, P. Rutgeerts, WJ. Sandborn, D. Tarabar,S. Huyck, A. Khalifa, C. Marano, G. Philip, R. Yao, H. Zhang, F. Cornillie
    Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab.
    Inflamm Bowel Dis 2018
     
  • W. Reinisch, PR. Gibson, WJ. Sandborn, BG. Feagan, R. Strauss, J. Johanns, L. Padgett, OJ. Adedokun, JF. Colombel, J. Collins, P. Rutgeerts, D. Tarabar, C.
  • Marano
    Long-term Benefit of Golimumab for Patients with Moderately-to-Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension.
    J Crohns Colitis. 2018 Jun 18
     
  • N. Rohr-Udilova, E. Bauer, G. Timelthaler, R. Eferl, K. Stolze, M. Pinter, M. Seif, H. Hayden, T. Reiberger, R. Schulte-Hermann, M. Peck-Radosavljevic, D. Stoiber, M. Trauner
    Impact of glutathione peroxidase 4 on cell proliferation, angiogenesis and cytokine production in hepatocellular carcinoma
    Oncotarget. 2018 Jan 22;9(11):10054-10068
     
  • N. Rohr-Udilova, F. Klinglmüller, R. Schulte-Hermann, J. Stift, M. Herac, M. Salzmann, F. Finotello, G. Timelthaler, G. Oberhuber, M. Pinter, T. Reiberger, E. Jensen-Jarolim, R. Eferl, M. Trauner
    Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma
    Sci Rep. 2018 Apr 18;8(1):6220. doi: 10.1038/s41598-018-24437-5
     
  • B. Scheiner, PR. Stammet, S. Pokorny, T. Bucsics, P. Schwabl, A. Brichta, J. Thaler, K. Lampichler, A. Ba-Ssalamah, C. Ay, A. Ferlitsch, M. Trauner, M. Mandorfer, T. Reiberger
    Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
    Wien Klin Wochenschr. 2018 Jun 18
     
  • M. Schneeweiss, B. Peter, S. Bibi, G. Eisenwort, D. Smiljkovic, K. Blatt, M. Jawhar, D. Berger, G. Stefanzl, S. Herndlhofer, G. Greiner, G. Hoermann, E. Hadzijusufovic, KV. Gleixner, P. Bettelheim, K. Geissler, WR. Sperr, A. Reiter, M. Arock, P. Valent
    The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
    Haematologica. 2018 May;103(5):799-809
     
  • M. Tardelli, T. Claudel, FV. Bruschi, M. Trauner
    Nuclear Receptor Regulation of Aquaglyceroporins in Metabolic Organs.
    Int J Mol Sci. 2018 Jun 15;19(6).
     
  • JP. Arab, M. Arrese, M. Trauner
    Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
    Annu Rev Pathol. 2018 Jan 24;13:321-350
     
  • M. Wewalka, A. Drolz, B. Seeland, M. Schneeweiss, M. Schmid, B. Schneeweiss, C. Zauner
    Different enteral nutrition formulas have no effect on glucose homeostasis but on dietinduced thermogenesis in critically ill medical patients: a randomized controlled trial
  • Eur J Clin Nutr. 2018 Apr;72(4):496-503